#USA #Clinical Trials #CARY #WCG #Pinnacle Award

WCG Pinnacle Award Celebrates Excellence in Clinical Trials

On June 11, 2025, WCG, a prominent leader in enhancing clinical research, celebrated the winners of the inaugural Pinnacle Award for Site Relationships. This prestigious award aims to recognize outstanding organizations that have fostered exemplary partnerships between clinical trial sites, sponsors, and contract research organizations (CROs).

The winners were identified through the 2025 CenterWatch Global Site Relationship Survey, which gathered insights from over 12,000 participants and received nearly 29,000 ratings on various factors important to clinical research, such as communication quality, professionalism, technological use, and effective management of sites.

Recognized Leaders in Clinical Trial Collaboration

The award includes six categories, recognizing different areas of excellence among various organizations. The champions for the 2025 Pinnacle Award include:

• - Bayer and Novo Nordisk as Overall Site Relationship Leaders
• - IQVIA and Medpace for their Leadership in Professionalism and Communication
• - Parexel recognized for Leadership in Technology

These organizations exemplify commitment towards enhancing clinical research and are noted for their ability to cultivate strong relationships with sites, thereby improving operational efficiency and participant diversity in clinical trials.

The Significance of Strong Site Relationships

Sam Srivastava, CEO of WCG, expressed his pride in celebrating entities who are paving the way in site relationships, stating, "The Pinnacle Award recipients exemplify the industry's drive toward innovation and excellence, enhancing clinical trial collaborations. Their dedication inspires continued progress in clinical research throughout the industry."

Mette Andersen, General Manager of Data Insights at WCG, remarked on the crucial role strong site relationships play in the successful navigation of clinical trials, stating, "These award-winning organizations have shown that fostering site connections leads to more efficient operations and improved outcomes in clinical research."

Insights from the Global Survey

The WCG CenterWatch Global Site Relationship Survey has been a valuable tool for sponsors and CROs since its inception in 1997. It aids in benchmarking practices and facilitating improvements in site relationships. The data gathered helps in shaping operational strategies that enhance collaboration and performance.

WCG has developed a robust dataset that encompasses global performance metrics and longitudinal data across all therapeutic areas, empowering organizations to make data-driven decisions that enhance their operational strategies. Sponsors interested in leveraging this data can still access tailored reports to strengthen their specific site relationships and drive continuous improvement.

The 2025 report’s trends can be explored in greater detail at WCG's official industry report. For organizations eager to learn more about WCG’s data insights, detailed information can be found on their website at WCG Data Insights.

About WCG

WCG is at the forefront of accelerating clinical research globally, supporting biopharmaceutical companies, CROs, research institutions, and site partners. With over 55 years of experience, WCG continues to deliver innovative tech-enabled solutions while prioritizing the safety and efficiency of clinical studies. As a trusted partner in the realm of clinical trials, WCG aims to enable the swift delivery of life-improving therapies.

For more information about WCG and their initiatives in clinical research, visit WCGClinical.com or follow them on LinkedIn or X @WCGClinical.